_id
69130a70ccc777a4e85d7c1e
Ticker
KLTOW
Name
Klotho Neurosciences, Inc
Exchange
NASDAQ
Address
13576 Walnut Street, Omaha, NE, United States, 68144
Country
USA
Sector
Industry
Currency
USD
Website
https://klothoneuro.com
Description
Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
Last Close
0.1672
Volume
5412
Current Price
0.1
Change
0.01
Last Updated
2026-01-04T16:03:41.500Z
Image
data:image/webp;base64,UklGRjgLAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSOgHAAAB8HDbtrIn2rbPa+x9HGc8VHAI7u7u7h7KBWjuThnupUgJ7k64SvFWuHsJ7u6eC4ecx7wkCSdnREwAgTaWsIqDf9m7d8ecD7O5uAS7sdRb+1KeJE93vyyADTJD5KhEebp7dPulRHk6F4cJKkPofL3c8Um1XFljYot3PCTvWXcc6ziu6zrm9VjX53MtjNaSSqnI14WYjNiowc90rzYuSbs2cI5L0q0Pt6RnX/pvovdWCo5hgF8bonNWb9a6ecNSqTBOgAyYXA0++qhhLN1zwW8jmDKXr+fRbgesld4sPf6QPP/tzUNzYQJiCem27uxDz//gxM8fYvnrXVYMJn4YE+KhorQizM2U71tJOt0Wa17NpdpheZ7f/1LyHh14L8vpQuxpzc52zBpBbMXlel4QYg4tf/es59fXxppXcejmeXr+Yk7zdhN23fKkxwnNyp0pELW9Dnu+GbwhW3NpNDF7VvuY+O8Xfn3Dqxi6y9PqxuPP5odUb868KM/zHj5ftuDGr8vv61Qhsh7UZdqsCuere7UHJEqtMSmy1Hisp1qEmXm7GlVqm3x9TyhpTy+nZiSUkfL3dVLzaUJ1muqJzqTDpMBYtkk/Fr0aD98O45uhQEyTReeePnz49PLs8i7GocI1HUnHh9drEvfws4VK7I2TApf3ExPVjyLXl1lL7KXeuBYMucqVKRwKxoLLfGkyXeNo/GgITR5oC9YkYyyzdWPUg/7kPro8jH6qjDXGkKwxgKXYPT2Ng+r3B5F65QudzYdNxpJhpybR+ulAcox4o+Czh4Ww/L8xxpCsYYZ0uTC9Pydi1/ph3pNGuMk4FL+m/dmpcfVLyPyPfo/EJPGqqXdIR4oD8f+Et05UG3wpKOv/ef2h7FT9hswbpO64BNKS44h0vRX2rdx08Pvfxk1BOcUx82x+nHJHpV2psAHBIeu8p54WlzQ+5utSKZwUFD1Ymuh3sjlDb0qXy2AJsLGm9td7nnlr2uTYr/2R2GQssRPy4dLiH3m6WBpLwK3FpM9TuVW2romahzU2KaxTMjbjgKOe53+5JAMOr9N1wMBy3S/f+zOwSbhEN1qQIE8JK6pjLa/Z2BCqP9YKQg8sy4gFDIXXyfN0fEJ9MATlt3pZGio/2xqDwfL2BXnehqbZLI5DEBpiryuhUVZYotkGh2JXpd3lc9TG5xqCo710+szZC2NLvdQ7ELVJ/h9DSbUgDkuQrpIqk6Nlg/AV2pmG9lI8jkMDlcQGR+RN3X871sXQQyofs1WPMn1weuXEiU92R2OCwFDime7sPHNoy+JKlaURxaUZxLQePH31JXUJknKPNCMqR7V+U+vlT9Af3aTWuOBjuE76CJa5WbJYLLnOas/3Uikzb+34TypP08NymGAo+lT3dx/YuGFO6vR/ad8U3cnHO5/P2vjHZfnbYF8fhF3T1EwV3+oxLU3uO9owRSqJBZdBetkxOJisn8MxOJSXJgySytfZsXRsj4zf6EXnoDAUefHixpZfZzRmpNSsntQjrOu3/9p59L5evh0UGEaoXeNPFvfLdFnnY7NfVrwFS8adSsiMCY7IXePBMlfqA6N0L+17P/Qu0+COjhGklvTLc5N2gV+700PuYxpQM37riTvSZ0FifQ7pK3Q/6+lUERyXt3XUhah9SsyLCQbXElZm8Al5OlQMAw79NQ5KvtAMGwzGkObDZQny6/bUHBgAwwfnazFPqovrOOY1WXydDiZKOjGkRBiWJCzFP69xRZtisIBjX4dD8d1+z3u0vklqahfBJIGxLqOkgcU++7xh6bRYJ3CWuOtS4ppqOITPqIGTFMZhi87kz/nJ30rcPjQPNlCWknekMz3JNjEfOU42TIEl5wmtxUfYW2eUeL4pTmAMvg3S7sIQMe9IwbJqgpuMQ/nrmkTuaT5iVkqP47AB8fG+tOoNvv4CJl795dVG+45tIiItP8j/vBYmAIaQeP2dAaqdmhnKeKkWTjKWHCe1bvO2UCYuJfx36XhYcsb+//9Zcpz0SjHxQ3Je/J0hulQ4BcZhu/RzNKPPF4PYA9IgXMAYkjfGobhGQJtrn5DtzLobWowxyeAyXvqEMQ8b0GcFcQ/1Vzos1mCLt+/SpX0pBwihzuO8hNDk8Qgq35C64CN5S8UE/T39akvq3WgDi6Te+Cyhcbuf+RNf+J9e/LFUhCVuIT2O56Hl7UGTpT1RmBRgWKKXakudh13JVrzIA62MgKxr5CnZF1s+SpW3PpErLuSmpxL1uBaWlGW9JK1pe3MMEQcnEa8Xlahx8d6/xwy5M+rzc3svSp4OfFktBGfq3l77XnpeZywpN9S8pWf6hZDVKyOpKg0qtOrdj06RfXve1OtrxF7ec1Oed33n5NELPPl19yMsr+pS55ISnyzdcCQtpNqlW4ViaP8HLfa9UeJCJk6XyDTq/BMl6T35oyAur+6Qdcl9edrTuUrhdJ9Kg+CrBbRfT+ODVDwTDjn7rd5/6capXbMrgyWQBlNzzMZzT3VuRp2SD3S3IGsmMuoXhqyl/XEoPCbERJSsmMsBDIE1jiGmYOky+bNFMk7aGtI8P+MHM2caFd/x9boWhwtgfZbAuy5JGmK2SHtLgOuSJzdhbY5oOMZYx3EMr9dax7HWWPIdkOdf3bZckbJVus65Kk0OxRDMhpglz+R5evBcku52wxqC2xLW+He/JHm6PqUs1hDsxiUq/3tfTZk8rklmF9cQaFZQOCAqAwAAcBAAnQEqQABAAD61UqBMpySjIigUDKjgFolqALEmAVgeSxI6ArbUc8V6AP+Hvje8Y/4J/Muiew2VJwA42fABu71AOjaauKc030aZYNeww4qAmpgxTLzBlWiJp772UtR5T1IzPYu7fdAnSCUTTyB7NAMt+ccF0U3/c2MbFpLkjPbnxBlr7skYZU0z4IAA/v2cCcPxS3B459SqyfjnOL5l3y6mxmits3HpM/F/PCBUvCNsNf8GoumdIJpsTbP5TWaEl7mtpA2ov7T/t1siKajpO/PXyoOJTo5wOWoltDc+1Y7Y0tj+53Ssqkc4mTrzgv04C5t+Xl2TOcUAHOtP5n+CnCNfCWCFJy8uDGZhr4qSjDNj8iq+DOUZ+ERmmWmXelv3AH7v4tVcqPKWJ3XYUem0uVAqM1UNzcX9uE8m8453eKHvv+UKq4bHxEmAh1dQCDxkBk55GzMyPUkDUENyGSSWRE7t6hg/IjTIvRplsM6SDzP7TgFxQsRLS0YBg0HYp3LSkPws8a3UjqU5/dmhV9MiyGJ8ALpX7pFDz0Fs7/zo3JsX4pLqRJuu03jqIUxD1nleQ/rL49tZRZ04Move9KnSuqZv4DmJ9BvIqjdaDhWMUfbR5601XyWTs3tole1uznWfRS55aU6hsXms/29NkcLMFPM3V1Z0g69fJP/W3vXChLifad+cbgZBjwDdGCGFBlU+S7wzdqIUNf09M81BRgZb34/3CLllWoTzctTbnd2J7Z038LlIkMDAKem8IsdAaPhj7xvVDK9y2rZVxPL5JwWXabpQ6y1TW0IGspQJ7ImgFhqB+tu2WpZj8W52rzhiN1EF6A7ngdIMATl3e20R/0G+aXdpoRTW/iTLj2rthWd/bwIHIMFq9mmY/B9HSG35nvv+eUBBoFEAnnBCAezxebN/ddVmaGfdqYItajpJob9z6Kbr/ymmZFtJVicJpWEyY9rrMOiz9er1XLlXGg9o1S+4C1BACzLAVkqKIiA2NQNQCzq7GSJW+kdUquQijRrrf54rirqKiel3AFBPLsD7IZhRNctFujXUUmPEHsojeMmJTSonim7Df/zcAAAA
Ipo Date
2024-09-17T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
1853304
Operating Income
-1853304
Interest Expense
1177999
Pretax Income
-2895585
Net Income
-2895585
Eps
-0.0487336530995183
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-1717587
Operating Margin
-
Total Other Income Expense Net
-1042281
Cash
7348034
Short Term Investments
-
Receivables
339253
Inventories
-
Total Current Assets
7773590
Property Plant Equipment
-
Total Assets
10073144
Payables
34905
Short Term Debt
-
Long Term Debt
-
Total Liabilities
145891
Equity
9927253
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
26602
Cash From Operations
-1088212
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
5300
Net Change In Cash
-1082912
Cf_currency_symbol
USD
PE
-
PB
0.5985194393655526
ROE
-29.16803873135902
ROA
-28.745593232857587
FCF
-1088212
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2
Quality Investing Score
2.5
Value Investing Score
6.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
1853304
Quarters > 0 > income Statement > operating Income
-1853304
Quarters > 0 > income Statement > interest Expense
1177999
Quarters > 0 > income Statement > pretax Income
-2895585
Quarters > 0 > income Statement > net Income
-2895585
Quarters > 0 > income Statement > eps
-0.0487336530995183
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
59416539
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1717587
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-1042281
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
7348034
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
339253
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
7773590
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
10073144
Quarters > 0 > balance Sheet > payables
34905
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
145891
Quarters > 0 > balance Sheet > equity
9927253
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2895585
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
26602
Quarters > 0 > cash Flow > cash From Operations
-1088212
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
5300
Quarters > 0 > cash Flow > net Change In Cash
-1082912
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.0487336530995183
Quarters > 0 > ratios > PB
0.5985194393655526
Quarters > 0 > ratios > ROE
-29.16803873135902
Quarters > 0 > ratios > ROA
-28.745593232857587
Quarters > 0 > ratios > FCF
-1088212
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
1892852
Quarters > 1 > income Statement > operating Income
-1892852
Quarters > 1 > income Statement > interest Expense
1760025
Quarters > 1 > income Statement > pretax Income
-4093231
Quarters > 1 > income Statement > net Income
-4093231
Quarters > 1 > income Statement > eps
-0.07766589308744254
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
52703070
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-2333206
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-2200379
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
8430946
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
8546332
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
10845886
Quarters > 1 > balance Sheet > payables
12631
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
195409
Quarters > 1 > balance Sheet > equity
10650477
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-4093231
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-457615
Quarters > 1 > cash Flow > cash From Operations
-1968431
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
9833508
Quarters > 1 > cash Flow > net Change In Cash
7865077
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.07766589308744254
Quarters > 1 > ratios > PB
0.494842343680945
Quarters > 1 > ratios > ROE
-38.432372559463765
Quarters > 1 > ratios > ROA
-37.73994120904461
Quarters > 1 > ratios > FCF
-1968431
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
1586968
Quarters > 2 > income Statement > operating Income
-1586968
Quarters > 2 > income Statement > interest Expense
553937
Quarters > 2 > income Statement > pretax Income
-2233982
Quarters > 2 > income Statement > net Income
-2233982
Quarters > 2 > income Statement > eps
-0.08116582384083988
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
27523678
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1680045
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-647014
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
565869
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
687712
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
2987266
Quarters > 2 > balance Sheet > payables
66549
Quarters > 2 > balance Sheet > short Term Debt
1767920
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2348557
Quarters > 2 > balance Sheet > equity
638709
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-2233982
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-464888
Quarters > 2 > cash Flow > cash From Operations
-1553747
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
2055875
Quarters > 2 > cash Flow > net Change In Cash
502128
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.08116582384083988
Quarters > 2 > ratios > PB
4.30926728760672
Quarters > 2 > ratios > ROE
-349.7652295489808
Quarters > 2 > ratios > ROA
-74.78349768651336
Quarters > 2 > ratios > FCF
-1553747
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
20
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
1851652
Quarters > 3 > income Statement > operating Income
-1851652
Quarters > 3 > income Statement > interest Expense
296583
Quarters > 3 > income Statement > pretax Income
-2067263
Quarters > 3 > income Statement > net Income
-2067263
Quarters > 3 > income Statement > eps
-0.07633652703389084
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
27080915
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-1770680
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-215611
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
63741
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
157811
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
2457365
Quarters > 3 > balance Sheet > payables
63686
Quarters > 3 > balance Sheet > short Term Debt
271753
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1272020
Quarters > 3 > balance Sheet > equity
1185345
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2067263
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
308863
Quarters > 3 > cash Flow > cash From Operations
-944154
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
957000
Quarters > 3 > cash Flow > net Change In Cash
12846
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.07633652703389084
Quarters > 3 > ratios > PB
2.2846441331426717
Quarters > 3 > ratios > ROE
-174.40179863246564
Quarters > 3 > ratios > ROA
-84.12519100744089
Quarters > 3 > ratios > FCF
-944154
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
33
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
5540236
Annuals > 0 > income Statement > operating Income
-5540236
Annuals > 0 > income Statement > interest Expense
356603
Annuals > 0 > income Statement > pretax Income
-6150372
Annuals > 0 > income Statement > net Income
-6150372
Annuals > 0 > income Statement > eps
-0.31954444758081296
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
19247313
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-5793769
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-610136
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
63741
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
157811
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
2457365
Annuals > 0 > balance Sheet > payables
63686
Annuals > 0 > balance Sheet > short Term Debt
271753
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1272020
Annuals > 0 > balance Sheet > equity
1185345
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-6150372
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
150573
Annuals > 0 > cash Flow > cash From Operations
-2946512
Annuals > 0 > cash Flow > capital Expenditures
123497
Annuals > 0 > cash Flow > cash From Investing
-123497
Annuals > 0 > cash Flow > cash From Financing
3130942
Annuals > 0 > cash Flow > net Change In Cash
60933
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.31954444758081296
Annuals > 0 > ratios > PB
1.7195756903686268
Annuals > 0 > ratios > ROE
-518.8676714374296
Annuals > 0 > ratios > ROA
-250.28320986096895
Annuals > 0 > ratios > FCF
-3070009
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
24
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
631322
Annuals > 1 > income Statement > operating Income
-631322
Annuals > 1 > income Statement > interest Expense
76214
Annuals > 1 > income Statement > pretax Income
-707458
Annuals > 1 > income Statement > net Income
-707458
Annuals > 1 > income Statement > eps
-0.036756195527136694
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
19247313
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-631244
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-76136
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
2808
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
6648
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
2192706
Annuals > 1 > balance Sheet > payables
151259
Annuals > 1 > balance Sheet > short Term Debt
1467270
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1620989
Annuals > 1 > balance Sheet > equity
571717
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-707458
Annuals > 1 > cash Flow > depreciation
-
Annuals > 1 > cash Flow > change In Working Capital
260542
Annuals > 1 > cash Flow > cash From Operations
-446916
Annuals > 1 > cash Flow > capital Expenditures
13888
Annuals > 1 > cash Flow > cash From Investing
23852
Annuals > 1 > cash Flow > cash From Financing
350000
Annuals > 1 > cash Flow > net Change In Cash
-73064
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.036756195527136694
Annuals > 1 > ratios > PB
3.5652087426121666
Annuals > 1 > ratios > ROE
-123.74269087677993
Annuals > 1 > ratios > ROA
-32.2641521480764
Annuals > 1 > ratios > FCF
-460804
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
15
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
574374
Annuals > 2 > income Statement > operating Income
-574374
Annuals > 2 > income Statement > interest Expense
24366
Annuals > 2 > income Statement > pretax Income
-598593
Annuals > 2 > income Statement > net Income
-598593
Annuals > 2 > income Statement > eps
-0.031100081346419627
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
19247313
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-574227
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-24219
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
75872
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
250000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
329539
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
2539449
Annuals > 2 > balance Sheet > payables
8014
Annuals > 2 > balance Sheet > short Term Debt
1347518
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1360274
Annuals > 2 > balance Sheet > equity
1179175
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-598593
Annuals > 2 > cash Flow > depreciation
-
Annuals > 2 > cash Flow > change In Working Capital
-2380
Annuals > 2 > cash Flow > cash From Operations
-599573
Annuals > 2 > cash Flow > capital Expenditures
125408
Annuals > 2 > cash Flow > cash From Investing
-125408
Annuals > 2 > cash Flow > cash From Financing
500000
Annuals > 2 > cash Flow > net Change In Cash
-224981
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.031100081346419627
Annuals > 2 > ratios > PB
1.7285733217715775
Annuals > 2 > ratios > ROE
-50.76371191723027
Annuals > 2 > ratios > ROA
-23.571766946294257
Annuals > 2 > ratios > FCF
-724981
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
25
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
1109069
Annuals > 3 > income Statement > operating Income
-1109069
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-1109025
Annuals > 3 > income Statement > net Income
-1109025
Annuals > 3 > income Statement > eps
-0.05761973112818397
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
19247313
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-1109025
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
44
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
300853
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
304520
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
1041503
Annuals > 3 > balance Sheet > payables
15135
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
15135
Annuals > 3 > balance Sheet > equity
1026368
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-1109025
Annuals > 3 > cash Flow > depreciation
-
Annuals > 3 > cash Flow > change In Working Capital
3854
Annuals > 3 > cash Flow > cash From Operations
-284021
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
250000
Annuals > 3 > cash Flow > net Change In Cash
-34021
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.05761973112818397
Annuals > 3 > ratios > PB
1.9859255614945126
Annuals > 3 > ratios > ROE
-108.05334928602606
Annuals > 3 > ratios > ROA
-106.4831306294845
Annuals > 3 > ratios > FCF
-284021
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
35
Valuation > metrics > PE
-0.0487336530995183
Valuation > metrics > PB
0.5985194393655526
Valuation > final Score
70
Valuation > verdict
40.1% Undervalued
Profitability > metrics > ROE
-29.16803873135902
Profitability > metrics > ROA
-37.24900592904951
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.014696009057087595
Risk > metrics > Interest Coverage
-1.573264493433356
Risk > final Score
54
Risk > verdict
High
Liquidity > metrics > Current Ratio
222.70706202549778
Liquidity > metrics > Quick Ratio
222.70706202549778
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
36.9073271239328
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
56
Prev Risks > 1
-5
Prev Risks > 2
5
Prev Liquidities > 0
100
Prev Liquidities > 1
29
Prev Liquidities > 2
34
Updated At
2026-01-20T22:05:58.536Z
Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShould I hold or sell KLTOW now - 2025 Short Interest & Detailed Earnings Play Alerts bollywoodhelpline.com
Read more →Will Envoy Medical Inc. stock gain from strong economy - Quarterly Trade Review & Consistent Return Investment Signals bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Klotho Neurosciences, Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.